Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 8/20 | 0.54 |
| ▸ | HCAR2 | Q8TDS4 | 6/20 | 0.50 |
| ▸ | ALPL | P05186 | 5/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31467460 | 0.98 | HCAR3 (0.53) | HCAR3HCAR2ALPLCA9CA12 | |
| SCHEMBL1527555 | 0.89 | HCAR2 (0.53) | HCAR3HCAR2ALPLCA9CA12 | |
| SCHEMBL16763221 | 0.88 | HCAR3 (0.50) | HCAR3HCAR2ALPLCA9CA12 | |
| Hydrochloric Acid SCHEMBL27449787 | 0.88 | HCAR2 (0.51) | HCAR3HCAR2ALPLCA9CA12 | |
| SCHEMBL4790447 | 0.88 | HCAR2 (0.54) | HCAR3HCAR2ALPLCA9CA12 | |
| SCHEMBL1431995 | 0.85 | ALPL (0.54) | HCAR3HCAR2ALPLCA9CA12 | |
| SCHEMBL6622541 | 0.84 | PLA2G10 (0.42) | HCAR3HCAR2ALPLCA9CA12 | |
| SCHEMBL5599241 | 0.82 | HCAR3 (0.47) | HCAR3HCAR2ALPLCA9CA12 | |
| SCHEMBL6109395 | 0.82 | HCAR3 (0.43) | HCAR3HCAR2ALPLCA9CA12 | |
| SCHEMBL6109448 | 0.81 | HCAR3 (0.45) | HCAR3HCAR2ALPLCA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109721538-A | A kind of novel synthesis of 1- methyl -3- propylpyrazol -5- carboxylic acid | 孙双 | 2019-05-07 | — | — | CN | claimed |
| EP-1362049-A1 | NOVEL PYRAZOLO-TRIAZOLES AND USE OF SAID COMPOUNDS FOR DYEING KERATINOUS FIBRES | L'OREAL (FR) | 2003-11-19 | — | — | EP | claimed |
| WO-2002064596-A1 | NOVEL PYRAZOLO-TRIAZOLES AND USE OF SAID COMPOUNDS FOR DYEING KERATINOUS FIBRES | L'OREAL (FR) | 2002-08-22 | — | — | WO | claimed |
| EP-1077214-A1 | An improved process for preparing a pyrazolopyrimidinone derivative | Orchid Chemicals & Pharmaceuticals Ltd. (IN) | 2001-02-21 | — | — | EP | claimed |
| EP-3157938-B1 | HETERO FUNCTIONAL BINDING SYSTEMS | ANTEO TECH PTY LTD (AU) | 2022-03-16 | — | — | EP | disclosed |
| US-10768176-B2 | Hetero functional binding systems | ANTEO TECHNOLOGIES PTY LTD (AU) | 2020-09-08 | — | — | US | disclosed |
| US-20170115285-A1 | HETERO FUNCTIONAL BINDING SYSTEMS | ANTEO TECHNOLOGIES PTY LTD (AU) | 2017-04-27 | — | — | US | disclosed |
| EP-3157938-A1 | HETERO FUNCTIONAL BINDING SYSTEMS | Anteo Technologies Pty Ltd. (AU) | 2017-04-26 | — | — | EP | disclosed |
| WO-2016120530-A1 | A CARBOXAMIDE DERIVATIVE AND ITS DIASTEREOMERS IN STABLE CRYSTALLINE FORM | ORION CORPORATION (FI) | 2016-08-04 | — | — | WO | disclosed |
| WO-2015192183-A1 | HETERO FUNCTIONAL BINDING SYSTEMS | ANTEO TECHNOLOGIES PTY LTD (AU) | 2015-12-23 | — | — | WO | disclosed |
| EP-2261210-B1 | 3-SUBSTITUTED SULFONYL PIPERAZINE DERIVATIVE | MSD KK (JP) | 2014-10-22 | — | — | EP | disclosed |
| US-8367698-B2 | 3-substituted sulfonyl piperidine derivative | MSD K.K. (JP) | 2013-02-05 | — | — | US | disclosed |
| CN-1034503-C | Pyrazolopyrimidinone antianginal agents | PFIZER (US) | 1997-04-09 | — | — | CN | disclosed |
| CN-1028758-C | Pyrazolopyrimidinone antianginal agents | PFIZER (US) | 1995-06-07 | — | — | CN | disclosed |
| EP-0463756-B1 | Pyrazolopyrimidinone antianginal agents | PFIZER LTD (GB) | 1995-04-19 | — | — | EP | disclosed |
| US-5346901-A | Treatment of angina, hypertension, heart failure and atherosclerosis | PFIZER INC. (US) | 1994-09-13 | — | — | US | disclosed |
| US-5250534-A | Inhibitors of cyclic guanosine 3*,5*-monophosphate phosphodiesterase | PFIZER INC. (US) | 1993-10-05 | — | — | US | disclosed |
| CN-1068329-A | Pyrazolopyrimidinoneantianginal antianginal agents | PFIZER (US) | 1993-01-27 | — | — | CN | disclosed |
| EP-0463756-A1 | Pyrazolopyrimidinone antianginal agents | Pfizer Limited (GB) | 1992-01-02 | — | — | EP | disclosed |
| CN-1057464-A | Pyrazolopyrimidinoneantianginal antianginal agents | PFIZER (US) | 1992-01-01 | — | — | CN | disclosed |